Comparing dynamic treatment regimes using repeated-measures outcomes: Modeling considerations in SMART studies

Statistics in Medicine

Volumn 35, Issue 10, 2016, Pages 1595-1615

  Lu, Xi ^a   Nahum Shani, Inbal ^b   Kasari, Connie ^c   Lynch, Kevin G ^d   Oslin, David W ^d   Pelham, William E ^e   Fabiano, Gregory ^f   Almirall, Daniel ^b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^f UNIVERSITY AT BUFFALO   (United States)

Author keywords

Adaptive intervention; Longitudinal analysis; Marginal structural model; Sequential multiple assignment randomized trial

Indexed keywords

ALCOHOLISM; AREA UNDER THE CURVE; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; BEHAVIOR; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MANAGEMENT; DYNAMIC TREATMENT REGIME; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; OUTCOME ASSESSMENT; SEQUENTIAL MULTIPLE ASSIGNMENT RANDOMIZED TRIALS; STATISTICAL CONCEPTS; ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; CHILD; HUMAN; METHODOLOGY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ALCOHOLISM; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; STATISTICS AS TOPIC; TREATMENT OUTCOME;

EID: 84952691009     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.6819     Document Type: Article

References (53)

1. Robins J. A new approach to causal inference in mortality studies with a sustained exposure period-application to control of the healthy worker survivor effect. Mathematical Modelling. 1986; 7(9-12): 1393-1512.
2. Robins JM. The analysis of randomized and non-randomized aids treatment trials using a new approach to causal inference in longitudinal studies. Health Service Research Methodology: A Focus on AIDS. 1989; 113: 159.
3. Robins JM. Information recovery and bias adjustment in proportional hazards regression analysis of randomized trials using surrogate markers. In Proceedings of the Biopharmaceutical Section, vol. 24, American Statistical Association: Virginia, 1993; 24-33.
4. Robins JM. 1997. Causal inference from complex longitudinal data. In Latent Variable Modeling and Applications to Causality Springer: New York; 69-117.
5. Robins JM. Optimal structural nested models for optimal sequential decisions. In Proceedings of the Second Seattle Symposium in Biostatistics, Springer: New York, 2004; 189-326.
6. Lavori PW, Dawson R. A design for testing clinical strategies: biased adaptive within-subject randomization. Journal of the Royal Statistical Society: Series A (Statistics in Society). 2000; 163(1): 29-38.
7. Lavori PW, Dawson R. Adaptive treatment strategies in chronic disease. Annual Review of Medicine. 2008; 59: 443-453.
8. Murphy SA. An experimental design for the development of adaptive treatment strategies. Statistics in Medicine. 2005; 24(10): 1455-1481.
9. Thall PF, Millikan RE, Sung HG. Evaluating multiple treatment courses in clinical trials. Statistics in Medicine. 2000; 19(8): 1011-1028.
10. Thall PF, Sung HG, Estey EH. Selecting therapeutic strategies based on efficacy and death in multicourse clinical trials. Journal of the American Statistical Association. 2002; 97(457): 29-39.
11. Lunceford JK, Davidian M, Tsiatis AA. Estimation of survival distributions of treatment policies in two-stage randomization designs in clinical trials. Biometrics. 2002; 58(1): 48-57.
12. Wahed AS, Tsiatis AA. Optimal estimator for the survival distribution and related quantities for treatment policies in two-stage randomization designs in clinical trials. Biometrics. 2004; 60(1): 124-133.
13. Wahed AS, Tsiatis AA. Semiparametric efficient estimation of survival distributions in two-stage randomisation designs in clinical trials with censored data. Biometrika. 2006; 93(1): 163-177.
14. Almirall D, Nahum-Shani I, Sherwood NE, Murphy SA. Introduction to smart designs for the development of adaptive interventions: with application to weight loss research. Translational Behavioral Medicine. 2014; 4(3): 260-274.
15. Tager-Flusberg H, Kasari C. Minimally verbal school-aged children with autism spectrum disorder: the neglected end of the spectrum. Autism Research. 2013; 6(6): 468-478.
16. Kasari C, Kaiser A, Goods K, Nietfeld J, Mathy P, Landa R, Murphy S, Almirall D. Communication interventions for minimally verbal children with autism: a sequential multiple assignment randomized trial. Journal of the American Academy of Child & Adolescent Psychiatry. 2014; 53(6): 635-646.
17. Orellana L, Rotnitzky A, Robins J. Generalized marginal structural models for estimating optimal treatment regimes, Technical Report, Department of Biostatistics, Harvard School of Public Health, 2006.
18. van der Laan MJ. Causal effect models for intention to treat and realistic individualized treatment rules, U.C. Berkeley Division of Biostatistics Working Paper Series. Working Paper 203, 2006.
19. Robins J, Orellana L, Rotnitzky A. Estimation and extrapolation of optimal treatment and testing strategies. Statistics in Medicine. 2008; 27(23): 4678-4721.
20. Bembom O, van der Laan MJ. Analyzing sequentially randomized trials based on causal effect models for realistic individualized treatment rules. Statistics in Medicine. 2008; 27(19): 3689-3716.
21. Orellana L, Rotnitzky A, Robins JM. Dynamic regime marginal structural mean models for estimation of optimal dynamic treatment regimes, part i: main content. The International Journal of Biostatistics. 2010; 6(2): 1557-4679.
22. Zhang B, Tsiatis AA, Laber EB, Davidian M. Robust estimation of optimal dynamic treatment regimes for sequential treatment decisions. Biometrika. 2013; 100(3): 681-694.
23. Moodie EE, Richardson TS, Stephens DA. Demystifying optimal dynamic treatment regimes. Biometrics. 2007; 63(2): 447-455.
24. Chaffee PH, van der Laan MJ. Targeted maximum likelihood estimation for dynamic treatment regimes in sequentially randomized controlled trials. The International Journal of Biostatistics. 2012; 8(1): 1-32.
25. Zhao YQ, Zeng D, Laber EB, Kosorok MR. New statistical learning methods for estimating optimal dynamic treatment regimes. Journal of the American Statistical Association. 2015; 110(510): 583-598.
26. Lavori PW, Dawson R. Dynamic treatment regimes: practical design considerations. Clinical Trials. 2004; 1(1): 9-20.
27. Lei H, Nahum-Shani I, Lynch K, Oslin D, Murphy SA. A "smart" design for building individualized treatment sequences. Annual Review of Clinical Psychology. 2012; 8: 21-48.
28. Nahum-Shani I, Qian M, Almirall D, Pelham WE, Gnagy B, Fabiano GA, Waxmonsky JG, Yu J, Murphy SA. Experimental design and primary data analysis methods for comparing adaptive interventions. Psychological Methods. 2012; 17(4): 457-477.
29. Miyahara S, Wahed AS. Assessing the effect of treatment regimes on longitudinal outcome data: Application to revamp study of depression. Journal of Statistical Research. 2013; 46(2): 233-254.
30. Wu CJ, Hamada MS. Experiments: Planning, Analysis, and Optimization, vol. 552. John Wiley & Sons: Hoboken, New Jersey, 2011.
31. Chakraborty B, Collins LM, Strecher VJ, Murphy SA. Developing multicomponent interventions using fractional factorial designs. Statistics in Medicine. 2009; 28(21): 2687-2708.
32. Neyman J, Iwaszkiewicz K, Kolodziejczyk S. Statistical problems in agricultural experimentation. Supplement to the Journal of the Royal Statistical Society. 1935; 2(2): 107-180.
33. Rubin DB. Bayesian inference for causal effects: the role of randomization. The Annals of Statistics. 1978; 6(1): 34-58.
34. Robins JM. Association, causation, and marginal structural models. Synthese. 1999; 121: 151-179.
35. Liang KY, Zeger SL. Longitudinal data analysis of continuous and discrete responses for pre-post designs. Sankhyā: The Indian Journal of Statistics, Series B. 2000; 62(1): 134-148.
36. Chiou WL. Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve. Journal of Pharmacokinetics and Biopharmaceutics. 1978; 6(6): 539-546.
37. Pruessner JC, Kirschbaum C, Meinlschmid G, Hellhammer DH. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology. 2003; 28(7): 916-931.
38. Robins JM. 2000. Marginal structural models versus structural nested models as tools for causal inference. In Statistical Models in Epidemiology, the Environment, and Clinical TrialsSpringer: New York; 95-133.
39. Hernán MA, Brumback BA, Robins JM. Estimating the causal effect of zidovudine on cd4 count with a marginal structural model for repeated measures. Statistics in Medicine. 2002; 21(12): 1689-1709.
40. Robins JM, Greenland S, Hu FC. Estimation of the causal effect of a time-varying exposure on the marginal mean of a repeated binary outcome. Journal of the American Statistical Association. 1999; 94(447): 687-700.
41. Vansteelandt S. On confounding, prediction and efficiency in the analysis of longitudinal and cross-sectional clustered data. Scandinavian Journal of Statistics. 2007; 34(3): 478-498.
42. Tchetgen Tchetgen EJ, Glymour MM, Weuve J, Robins J. A cautionary note on specification of the correlation structure in inverse-probability-weighted estimation for repeated measures, Harvard University Biostatistics Working Paper Series. 2012; Working Paper 140.
43. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986; 42(1): 121-130.
44. Sullivan PM, Anderson GL . A cautionary note on inference for marginal regression models with longitudinal data and general correlated response data. Communications in Statistics-Simulation and Computation. 1994; 23(4): 939-951.
45. Lai TL, Small D. Marginal regression analysis of longitudinal data with time-dependent covariates: a generalized method-of-moments approach. Journal of the Royal Statistical Society: Series B (Statistical Methodology). 2007; 69(1): 79-99.
46. Hirano K, Imbens GW, Ridder G. Efficient estimation of average treatment effects using the estimated propensity score. Econometrica. 2003; 71(4): 1161-1189.
47. Brumback BA. A note on using the estimated versus the known propensity score to estimate the average treatment effect. Statistics & Probability Letters. 2009; 79(4): 537-542.
48. Shortreed SM, Laber E, Scott Stroup T, Pineau J, Murphy SA. A multiple imputation strategy for sequential multiple assignment randomized trials. Statistics in Medicine. 2014; 33(24): 4202-4214.
49. van B S, Groothuis-Oudshoorn K. mice: Multivariate imputation by chained equations in r. Journal of Statistical Software. 2011; 45(3): 1-67. Available from: http://www.jstatsoft.org/v45/i03/.
50. Rubin DB. Multiple Imputation for Nonresponse in Surveys, vol. 307. John Wiley & Sons: Hoboken, New Jersey, 2009.
51. Flannery BA, Volpicelli JR, Pettinati HM. Psychometric properties of the penn alcohol craving scale. Alcoholism: Clinical and Experimental Research. 1999; 23(8): 1289-1295.
52. Mancl LA, DeRouen TA. A covariance estimator for GEE with improved small-sample properties. Biometrics. 2001; 57(1): 126-134.
53. Kilbourne AM, Abraham KM, Goodrich DE, Bowersox NW, Almirall D, Lai Z, Nord KM. Cluster randomized adaptive implementation trial comparing a standard versus enhanced implementation intervention to improve uptake of an effective re-engagement program for patients with serious mental illness. Implementation Science. 2013; 8(1): 1-14.